The Goldman Sachs Group, Inc. 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-12 12:36 pm Sale | 2026-06-30 | 13G | AMICUS THERAPEUTICS INC FOLD | THE GOLDMAN SACHS GROUP, INC. GS | 0 0.000% | -16,782,163 (Position Closed) | Filing |
| 2026-05-11 1:26 pm Purchase | 2026-03-31 | 13G | AMICUS THERAPEUTICS INC FOLD | THE GOLDMAN SACHS GROUP, INC. GS | 16,782,163 5.300% | 16,782,163 (New Position) | Filing |